Luye Pharma Completes Transfer of 25% Stake in Nanjing Luye to NJ Xinshi
I'm PortAI, I can summarize articles.
Luye Pharma Group Ltd. has finalized the transfer of a 25% equity stake in its subsidiary, Nanjing Luye, to NJ Xinshi. As of January 19, 2026, Nanjing Luye is now 75% owned by Luye Pharma and 25% by NJ Xinshi. This partnership agreement ensures that Luye Pharma retains control over Nanjing Luye's governance and strategic objectives.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments